Trial Profile
A Phase 1, Double-blind, Randomized, Placebo-controlled Single Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DS-1971a in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs DS-1971 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Inc
- 16 Oct 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 23 Apr 2014 New trial record